BSPED2012 Poster Presentations (1) (66 abstracts)
1Developmental Endocrinology Research Group, University of Glasgow, RHSC Glasgow, Glasgow, UK; 2Department of Paediatric Gastroenterology, RHSC Glasgow, Glasgow, UK; 3Department of Paediatric Biochemistry, RHSC Glasgow, Glasgow, UK.
Background: Puberty is understood to be commonly affected in adolescents with Crohns disease (CD) and ulcerative colitis (UC).
Objective: To determine the impact of IBD on pubertal status and pubertal growth.
Methods: Single centre prospective study over 12 months of 45 adolescents (boys, 23) with CD and 18 (boys, 12) with UC with a median age of 13.4 years (10, 16.6). Assessment included details of disease, anthropometry and biochemical markers of growth and puberty at T0 and T12.
Results: Individually, 10/45 (22%) adolescents with CD had one or more parameter affected: 7 had a HtSDS at diagnosis <−2, 6 had HtSDS <−2 at 0 and 12 months. No subjects remained prepubertal beyond the age at which 97% of population would have expected to enter puberty and only two adolescents with CD showed a delay in progression through puberty. In the whole group, HV showed an inverse association with ESR (r,−0.286; P=0.025).
T0 | T12 | ||||||
Group | Ht0 SDS | IGF1(0) SDS | IGFBP3(0) SDS | HV (cm/year) | Change Ht SDS | IGF1(12) SDS | IGFBP3(12) SDS |
CD | −0.14 (−2.6; 2.1) | −0.4 (−5.8; 2.6) | 0.45* (−1.5; 2.7) | 4.8 (0.2; 8.3) | 0.05 (−0.5; 0.6) | −0.93** (−2.3; 0.9) | 1.91** (−1.9; 3.6) |
UC | 0.25 (−1.8; 2.7) | −0.5 (−2; 1.4) | 0.3 (−1.9; 1.6) | 5.4 (1.4; 8.7) | 0.16 (−0.5; 0.4) | 0.02 (−1.3; 1.0) | 1.3 (−2.0; 2.1) |
*P<0.001; P<0.0001 as compared to the normal population. |
At T0 post-pubertal boys with CD had median urinary luteinising hormone:creatinine and follicle stimulating hormone:creatinine ratios that were significantly lower than the healthy population (P=0.01 and P=0.0001).
Conclusion: As a group, disorders of the pubertal growth spurt are more likely to occur in CD. Achieving disease control may be important in attaining normal growth during puberty.